Number of the records: 1  

Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin

  1. 1.
    SYSNO ASEP0191662
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JOstatní články
    TitleTumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin
    Author(s) Indrová, Marie (UMG-J) RID
    Bubeník, Jan (UMG-J)
    Mikyšková, Romana (UMG-J) RID
    Vonka, V. (CZ)
    Šmahel, M. (CZ)
    Žák, R. (CZ)
    Šímová, Jana (UMG-J) RID
    Bieblová, Jana (UMG-J)
    Mendoza, Luis (UMG-J)
    Jandlová, Táňa (UMG-J)
    Source TitleInternational Journal of Oncology. - : Spandidos Publications - ISSN 1019-6439
    Roč. 2002, č. 20 (2002), s. 643-646
    Number of pages4 s.
    Languageeng - English
    CountryGR - Greece
    KeywordsHPV16, IL-2 ; tumour vaccines ; gene therapy
    Subject RIVEB - Genetics ; Molecular Biology
    CEZAV0Z5052915 - UMG-J
    AnnotationOncogenic, moderately immunogenic, MHC class I- and class II-, B7(-), MK16/l/III ABC (MK16) cells were previously established by co-transfection of HPV16 E6/E7 and activated H-ras oncogene DNA into C57BL/6 kidney cells. Subcutaneous transplantation of these cells produced progressively growing local neoplasms which metastasized spontaneously to lungs and lymph nodes. The MK16 cells were implanted into syngeneic mice and used to examine whether the tumour lacking the signal molecules required for the induction of and sensitivity to T cell immunity is susceptible to local IL-2 treatment and IL-2 gene therapy. Peritumoural administration of human rIL-2 or murine IL-2 gene-modified MK16 tumour vaccine inhibited growth of subcutaneous MK16 tumour transplants and reduced the number of their lung metastases. These results indicate that experimental tumours which are MHC class I- and mimick in this respect a high proportion of human HPV16-associated carcinomas are suitable for IL-2 treatment.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2004

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.